首页> 外国专利> Caprolactamas replaced, a process for their preparation, Pharmaceutical compositions containing them, and their use for the preparation of composicionesfarmaceuticas In Treatment of tumors

Caprolactamas replaced, a process for their preparation, Pharmaceutical compositions containing them, and their use for the preparation of composicionesfarmaceuticas In Treatment of tumors

机译:己内酰胺替代品,其制备方法,包含它们的药物组合物及其在制备用于治疗肿瘤的复合法医学中的用途

摘要

1. The term "surrogate caprolactas" herein refers to a formula compound (1), wherein: R1 is C1-6 tar or C3-6 cyclopropyl tar; R2 is C1-6 solution or C1-6 tar; X is C1-12 tar, c2-12 alquenileno or c2-12; m is 0 O1; R3 is C3-8 cyclopropyl compound; Or the aromatic ring system selected from formula (2) to (5),Wherein: R4 is hydrogen, chlorine or methoxy; R5 is hydrogen, chlorine, c1-18 tar or c1-18 alkane; and Z esoorio, sulfur, N-H, on-ch3; or, where feasible, an acceptable drug acid addictive sa n-propane substituted by compounds containing these compounds, Or use these compounds to prepare for drug treatment or cancer screening, and a processing plant to make these compounds
机译:1.本文中的“替代己内酰胺”是指式化合物(1),其中:R 1为C 1-6焦油或C 3-6环丙基焦油; R 2为C 1-6溶液或C 1-6焦油; X是C1-12焦油,c2-12alquenileno或c2-12; m为0 O1; R3为C3-8环丙基化合物;或选自式(2)至(5)的芳环系统,其中:R 4为氢,氯或甲氧基; R5是氢,氯,c1-18焦油或c1-18烷烃; Z esoorio,硫,N-H,在ch3上;或在可行的情况下,可接受的药物酸性成瘾盐;或用含有这些化合物的化合物取代正丙烷,或将这些化合物用于药物治疗或癌症筛查,以及使用加工厂制备这些化合物

著录项

  • 公开/公告号AR023914A1

    专利类型

  • 公开/公告日2002-09-04

    原文格式PDF

  • 申请/专利权人 NOVARTIS AG.;

    申请/专利号AR1999P105796

  • 发明设计人

    申请日1999-11-15

  • 分类号C07D223/10;C07D405/12;C07D409/12;C07D403/12;C07D401/12;A61K31/55;A61P35/00;

  • 国家 AR

  • 入库时间 2022-08-22 00:46:27

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号